Bioextrax AB (publ) (BIOEX.ST)
Bioextrax AB (publ) operates in the Biotechnology industry of the Healthcare sector, headquartered in Lund, SN, SE. The stock last traded at $2.51, down 1.18% on the session, giving a market capitalisation of $119.5M. Its beta of 1.49 implies it has historically moved more than the broad market.
Bioextrax AB (publ) focuses on developing and commercializing a groundbreaking, biology-driven extraction system. This advanced technology facilitates the recovery of a variety of valuable materials from bacterial origins, such as bioplastic granules (PHA), organic hydrolyzed proteins, keratin fibers, different bio-oils, protein-rich co-products, and amino acids. The firm was founded in 2014 and conducts its operations from Lund, Sweden.
Bioextrax AB (publ) is most often compared with the following Healthcare names: